ROBERT E BURR

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism CATAUMET, MA NPI 1770533788

General Payments — all program years on this page

$2,674.43

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 144
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $403.14 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $403.1420

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,004.4057
2019 $903.5654
2020 $35.092
2021 $72.694
2022 $11.711
2023 $243.846
2024 $403.1420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086266831 Bayer Healthcare Pharmaceuticals Inc. $19.15 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096839839 Novo Nordisk Inc $22.08 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097183372 Novo Nordisk Inc $16.65 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097665770 Novo Nordisk Inc $18.22 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097821913 Novo Nordisk Inc $21.33 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105688497 AstraZeneca Pharmaceuticals LP $26.50 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112756182 ViiV Healthcare Company $14.63 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115471460 Amgen Inc. $19.77 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115471468 Amgen Inc. $29.21 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115471476 Amgen Inc. $15.70 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115471482 Amgen Inc. $19.33 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116824870 Insulet Corporation $22.47 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117517724 Amgen Inc. $13.46 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119476745 Medtronic, Inc. $21.61 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125262158 Abbott Laboratories $28.13 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125262162 Abbott Laboratories $23.03 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127041695 Kyowa Kirin, Inc. $18.20 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135336349 Lilly USA, LLC $16.62 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135381509 Lilly USA, LLC $20.57 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139587981 SANOFI-AVENTIS U.S. LLC $16.48 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.